Food and Drug Administration (FDA) has approved Biotronik's implantable cardioverter defibrillator (ICD) that is capable of producing an ultra-high energy electrical shock immediately on the first discharge.
Biotronik is the leading manufacturer of cardiovascular medical technology. According to the company, defibrillators have capacitors within them that store an electrical charge that is originally siphoned from a nearby battery.
Unlike previous high energy ICDs, the new Inventra DX ICD stays completely vigilant and is able to fire off 42 Joules of energy at any moment. The device uses only one lead that is capable of dual-chamber diagnostics, offering extra safety compared with using two leads while offering comparable continuous heart monitoring.